Impairments in HDAC functions and associated pathways have been implicated in pathogenesis of AD and HDAC inhibitors have shown promising applications for treatment of AD (Yang et al., 2017; Dubey et al., 2018). The gene discussed is HDAC9; the disease is Alzheimer disease.